Bayer has been granted a patent for an herbicidal composition containing glyphosate, amidoalkylamine surfactants, and co-surfactants. The concentrate solution includes a high concentration of glyphosate salt and excludes specific glyphosate salts. GlobalData’s report on Bayer gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Bayer, Peptide pharmacophores was a key innovation area identified from patents. Bayer's grant share as of February 2024 was 58%. Grant share is based on the ratio of number of grants to total number of patents.
Herbicide composition with glyphosate, amidoalkylamine surfactant, and co-surfactant
The granted patent (Publication Number: US11925179B2) discloses an aqueous herbicidal concentrate solution that includes a glyphosate component with a concentration greater than 300 grams acid equivalent per liter. The glyphosate component does not contain specific salts of glyphosate, such as the isopropylamine salt or n-propylamine salt. The solution also includes an amidoalkylamine surfactant of a defined structure (I), along with various co-surfactants with specific structures outlined in the claims.
Furthermore, the patent details the composition of the solution, including the types of co-surfactants used, such as alkoxylated tertiary amine, alkoxylated quaternary amine, alkoxylated tertiary etheramine, alkoxylated quaternary etheramine, alkoxylated etheramine oxide, alkoxylated alcohol, and phosphate ester of alkoxylated alcohol surfactant. The glyphosate salt in the solution can be selected from a range of options, including potassium salt, monoammonium salt, diammonium salt, sodium salt, and others. The concentration of the glyphosate component, as well as the mass concentration ratio of the amidoalkylamine surfactant to total co-surfactant, is also specified in the claims. Additionally, the patent includes a herbicidal method for applying the solution to unwanted plants to control or eliminate them effectively.
To know more about GlobalData’s detailed insights on Bayer, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.